JavaScript is disabled for your browser. Some features of this site may not work without it.
Please note that UPSpace will be unavailable from Friday, 2 May at 18:00 (South African Time) until Sunday, 4 May at 20:00 due to scheduled system upgrades. We apologise for any inconvenience this may cause and appreciate your understanding.
Reddy et al. present a worthy and timely review on breast
cancer in HIV-infected patients. There is clearly a paucity of
robust data on this important and common simultaneity. Some
older retrospective reports describe mainly experiences of
the pre-antiretroviral era. This information is outdated. Some
good epidemiological studies have recently been published,
such as that from Soweto by Cubasch et al. As pointed out by
Reddy et al. there is a great dearth of knowledge that would
come from prospective studies of the management of breast
cancer in HIV-infected patients. Intuition might dictate that
the outcome of both surgical and adjuvant treatment of breast
cancer in these patients would be poor because of the effect on
immunity.